Monday, 21 Sep 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Finance
  • Clinical trial results
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US

Medical Device

  • Company
  • Drug
  • Deals
  • Policy / Regulatory
  • Medical Device
  • R&D
  • Digital
  • Legal / IP
  • Others
  • Hospital
  • General/Other
NMPA Issues Medical Device GMP Inspection Guidelines – Revised Production Quality Standards Take Effect November 1, 2026
NMPA

NMPA Issues Medical Device GMP Inspection Guidelines – Revised Production Quality Standards Take Effect November 1, 2026

China's National Medical Products Administration (NMPA) issued the "Guidelines for Inspection of Medical Device Production Quality Management Standards" (the "Inspection Guidelines"), confirming that the newly revised "Medical Device Production Quality…

September 16, 2026
Bio‑heart Partners with Shenqi Medical to Commercialize BioHeart Bioabsorbable Stent – Advancing "Interventional Treatment Without Implantation" in China's Coronary Market

Bio‑heart Partners with Shenqi Medical to Commercialize BioHeart Bioabsorbable Stent – Advancing “Interventional Treatment Without Implantation” in China’s Coronary Market

September 15, 2026
Peijia Medical Wins NMPA Approval for GeminiOne TEER System – A Novel Transcatheter Edge‑to‑Edge Repair Device for Mitral Regurgitation in China

Peijia Medical Wins NMPA Approval for GeminiOne TEER System – A Novel Transcatheter Edge‑to‑Edge Repair Device for Mitral Regurgitation in China

September 14, 2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Abbott Laboratories Receives FDA Approval for Tendyne TMVR System
AbbottCVD

Abbott Laboratories Receives FDA Approval for Tendyne TMVR System

May 29, 2025
Sino Medical Sciences Technology's AUCURA Flow-Diverting Stent Approved by NMPA
CancerNeurovita

Sino Medical Sciences Technology’s AUCURA Flow-Diverting Stent Approved by NMPA

May 29, 2025
China's NMPA Approves Lifetech's Aortic Fenestration Stent System
CVDHKG: 1302

China’s NMPA Approves Lifetech’s Aortic Fenestration Stent System

May 28, 2025
Jenscare Announces Positive 30-Day Results for LuX-Valve Plus in TRINITY Study
Clinical trial resultsCVD

Jenscare Announces Positive 30-Day Results for LuX-Valve Plus in TRINITY Study

May 26, 2025
Show More
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up